Plasma norepinephrine and epinephrine in untreated diabetics, during fasting and after insulin administration.
about
Decreased expression of beta1- and beta2-adrenoceptors in human diabetic atrial appendageRole of sympathetic nervous system in experimental hypertension and diabetes mellitusThe heart in diabetesAbnormal cardiac function in the streptozotocin-diabetic rat. Changes in active and passive properties of the left ventricle.Evaluation of transcendental meditation as a method of reducing stress.Determinants of human adipose tissue lipoprotein lipase. Effect of diabetes and obesity on basal- and diet-induced activity.Glucose transport and metabolism in adipocytes from newly diagnosed untreated insulin-dependent diabetics. Severely impaired basal and postinsulin binding activitiesEffect of metabolic clearance rate and hepatic extraction of insulin on hepatic and peripheral contributions to hypoglycemia.Glucagon response to hypoglycemia in sympathectomized man.Dual effect of insulin on plasma volume and transcapillary albumin transport.The influence of diabetes on cardiac beta-adrenoceptor subtypes.Epinephrine plasma thresholds for lipolytic effects in man: measurements of fatty acid transport with [l-13C]palmitic acidThe impact of streptozotocin-induced diabetes mellitus on cyclic nucleotide regulation of skeletal muscle amino acid metabolism in the rat.Epinephrine-induced insulin resistance in man.Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man.Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia.Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humansSympathoadrenal activity in fasting pregnant rats. Dissociation of adrenal medullary and sympathetic nervous system responses.Somatostatin- and epinephrine-induced modifications of 45Ca++ fluxes and insulin release in rat pancreatic islets maintained in tissue cultureParallel effects of β-adrenoceptor blockade on cardiac function and fatty acid oxidation in the diabetic heart: Confronting the maze.Long term treatment of moderate hypertension with penbutolol (Hoe 893d). II. Effect on the response of plasma catecholamines and plasma renin activity to insulin-induced hypoglycemia.Norepinephrine: hormone and neurotransmitter in man.Stimulation of heart rate by insulin: uninfluenced by beta-adrenergic receptor blockade in rabbits.The acute effect of insulin on renal haemodynamics and protein excretion in diabetics.Pathophysiology of sympathoadrenal system.The biochemistry of diabetes.Urinary excretion and plasma levels of norepinephrine and epinephrine during diabetic ketoacidosis.Insulin and glucose as modulators of the amino acid-induced glucagon release in the isolated pancreas of alloxan and streptozotocin diabetic rats.Effect of chronic alloxan diabetes and insulin administration on intestinal brush border enzymes.The psychophysiologic aspects of stress in juvenile diabetes mellitus.Insulin-counteracting hormones: their impact on glucose metabolism.The natural history of diabetic nephropathy in type I diabetes and the role of metabolic control in its prevention, reversibility and clinical course.Assessing the noradrenergic system in normal aging: a review of methodology.Acute effects of insulin on cardiovascular function and noradrenaline uptake and release.The effect of propranolol and phentolamine on serum gastrin concentration in response to respiratory acidosis in normal man.The effect of adrenergic blockade on the glucagon responses to starvation and hypoglycemia in man.Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. II. Effect of submaximal work and insulin-induced hypoglycaemia on plasma catecholamines and renin activity, blood pressure and pulse rate.A role for alpha-adrenergic receptors in abnormal insulin secretion in diabetes mellitus.Glucagon and diabetes. I. The failure of hyperglucagonaemia to influence the response of established diabetic ketoacidosis to therapy.Changes in systolic time intervals during treatment of diabetes mellitus.
P2860
Q24802547-B301D570-21DE-41AE-B562-154EB23A7102Q28370595-1F5E014E-1617-427B-8176-0B773D3F5DD2Q33606239-547784A4-B716-4469-B3CD-918E29546629Q34258155-2F6A1C1B-12C2-487D-A45A-DD119069C00BQ34311117-FBF12E0A-6BAD-4BCD-94CF-33C53B39011FQ34483858-E43E7570-232B-4821-A9BF-456312F9A586Q34567954-D02E0182-BF43-4027-8CF5-D91A2BCD8A7AQ34569198-2D8196F8-FEF8-4B7C-9DBE-FF987492CFB1Q35197978-D311EE92-61FD-4A83-9EF9-F2B41E968785Q35915598-1354652D-6E4A-439F-B456-87900AEAF649Q36761301-16FC6FD0-03CA-426E-837A-F529DDF43626Q37000183-A3E19B3F-9218-468A-BB11-6F250D78C518Q37020640-9BD6B547-3FF5-46C4-8B9C-6FC468E8024DQ37021517-A05C66A7-45FE-4C8E-B783-C0B93BE802EBQ37023863-4EAEE4D5-D505-4DBB-A76B-DCAF5245C6CCQ37034985-41A13ABB-8112-44CD-B56C-59EAE9766BCEQ37038049-8271EC69-13B9-4FA6-AC8A-80F195921EB3Q37039261-3030B376-A507-44AA-8B6B-2F810B916EE0Q37048602-CE84C79D-63F9-41BE-A0B9-63FECA6A22BAQ37939132-96025A24-383D-4E52-8DB8-637A96A62396Q39112809-371B8A85-EE73-4C13-B201-5252DB09E935Q39183968-E68AC72F-C51D-4177-BD3B-A37457CC7205Q39295093-2B0C7156-9151-4360-A442-76E2FC2268A5Q39510741-1B1E4517-C3FE-442B-8D23-F7702AE81953Q39561130-99534F04-DFE8-408B-AB81-428938306B62Q39650599-A092D5BA-F205-4C72-A4C8-208050870789Q39686315-B985014B-205D-4D5A-8045-5F516CA801D7Q39732494-090A4A73-FF2C-4FA5-AC4E-EDCC27EA3F15Q39855438-69236E99-34C8-4D70-B6EC-C0267F14F9F7Q40084254-E1FAE16D-AEDF-4FAB-B56A-6F16095BCED1Q40147841-07B26872-00D6-4828-A286-6EF25B0AB82DQ40150376-71CC1414-6A42-43FE-85BC-D5250A0429A6Q40163169-2CEA905E-FEEB-4781-A33C-38BD4CB2B079Q40166327-612FE67B-9820-49EB-8312-7C1C79CAD678Q40347791-68738F9B-F82F-4F9E-B819-C5548AA39328Q40368822-3AA10727-0844-445E-8F55-584069DDCDC1Q40772313-CCA58973-2EB3-4873-8D3F-6746808C4AFAQ40982693-8C947206-BC54-48E3-8C8B-33DC11277E96Q41280280-A9BF05C5-BB3F-4E70-84D7-8795AD4B7D26Q41328981-7A203E9D-1FE4-4054-9343-A715AFF0E970
P2860
Plasma norepinephrine and epinephrine in untreated diabetics, during fasting and after insulin administration.
description
1974 nî lūn-bûn
@nan
1974年の論文
@ja
1974年学术文章
@wuu
1974年学术文章
@zh
1974年学术文章
@zh-cn
1974年学术文章
@zh-hans
1974年学术文章
@zh-my
1974年学术文章
@zh-sg
1974年學術文章
@yue
1974年學術文章
@zh-hant
name
Plasma norepinephrine and epin ...... after insulin administration.
@en
Plasma norepinephrine and epin ...... after insulin administration.
@nl
type
label
Plasma norepinephrine and epin ...... after insulin administration.
@en
Plasma norepinephrine and epin ...... after insulin administration.
@nl
prefLabel
Plasma norepinephrine and epin ...... after insulin administration.
@en
Plasma norepinephrine and epin ...... after insulin administration.
@nl
P356
P1433
P1476
Plasma norepinephrine and epin ...... after insulin administration.
@en
P2093
Christensen NJ
P356
10.2337/DIAB.23.1.1
P407
P577
1974-01-01T00:00:00Z